Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib and Radiotherapy in Recurrent Glioblastoma
NCT04715620Phase 2Unknown
- Sponsor
- Tianjin Huanhu Hospital
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in glioblastoma (GBM), sponsored by Tianjin Huanhu Hospital. Status: unknown.
02
Drugs
niraparib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04715620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04715620.